April 13, 2023

Prostate cancer disparities have been well documented, and this study analyzes the way they manifest in the emotional and psychosocial lives of patients who have already undergone treatment, as well as their partners. Disparities in prostate cancer outcomes are caused by a variety of factors and result in a variety of different effects, including effects...

Black men have historically faced worse outcomes from prostate cancer, and this study provides a meta-analysis of past research on this topic in order to discuss ways to move forward. Prostate cancer is the most common type of cancer diagnosed in men in the United States. Although there have been advancements made in the screening...

Darolutamide was well-tolerated by Black/African-American patients, and similar safety profiles were observed across the overall trial group. Prostate cancer (PC) is the most common cancer among men in the United States (US) and is the world’s second most common cancer after lung cancer. Furthermore, PC is associated with a high incidence and mortality rate in...

Long-chain omega-3 fatty acid (LCn3) with MAG-EPA improves urinary irritation and bowel function in patients treated with radical prostatectomy. Prostate cancer is a highly prevalent cancer that can negatively affect patients’ quality of life. Radical prostatectomy is a common treatment for intermediate- to high-grade prostate cancer, but it often has side effects such as sexual...